The risk of myocardial infarction (MI) in the rivaroxaban 5 mg group was significantly lower than that of the control group (RR 0.83, 95% CI: 0.69-0.99, P= … Source link

Patients received apixaban (39.6%), rivaroxaban (33.3%), or dabigatran (27.1%). During a median follow-up of 30 (IQR, 20.5 – 41.5) months, recurrent … Source link

A small number of patients experienced major bleeding, though this happened infrequently. For critically ill patients, full-dose heparin also decreased … Source link

Heparin has been a standard workhorse, blood thinning agent used to flush cannulas, given as a subcutaneous injection to prevent clotting and also … Source link

Among patients with coronavirus disease 2019 (COVID-19), there may be a contribution of thrombosis and inflammation to the risk of death and … Source link

Anticoagulation with heparin could increase survival and reduce the need for organ support in patients hospitalised with moderate COVID-19, compared … Source link

In our study, non-heparin blood thinners and intravenous immunoglobulin were both associated with better patient outcomes, providing the first clinical … Source link

Study results have set a new standard of care for moderately ill hospitalized COVID-19 patients around the world using an affordable, accessible and … Source link

















